Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bavarian Nordic ADR
(OP:
BVNRY
)
13.78
+0.27 (+2.03%)
Streaming Delayed Price
Updated: 3:58 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bavarian Nordic ADR
< Previous
1
2
3
Next >
VRAX Stock Alert: Why Is Virax Biolabs Up 120% Today?
August 01, 2022
With monkeypox infections rising, Virax Biolabs’ PCR test for the underlying virus is bolstering sentiment for VRAX stock.
Via
InvestorPlace
Monkeypox Stocks On The Move: What Investors Should Know About The Outbreak
August 01, 2022
The World Health Organization has declared the 2022 outbreak of monkeypox a global health emergency. The monkeypox crisis isn't as severe as the COVID-19 pandemic, but it has a number of health care...
Via
Benzinga
Why Is SIGA Technologies (SIGA) Stock Plunging 23% Today?
July 29, 2022
SIGA stock is sinking lower after the FDA released a report, stating that TPOXX has not demonstrated efficacy in humans against monkeypox.
Via
InvestorPlace
Monkeypox Stocks SIGA, GOVX, BVNRY, CHMX, EBS Soar on Global Health Emergency
July 25, 2022
Drugs and vaccines used against smallpox are seen as the first line of defense against the rising tide of monkeypox infections.
Via
InvestorPlace
SIGA Stock Soars as WHO Declares Monkeypox Global Health Emergency
July 25, 2022
It's not every day that SIGA stock trends in the financial media, but today vaccine stocks are in focus due to the spread of monkeypox.
Via
InvestorPlace
Bavarian Nordic's Monkeypox Vaccine Gets Thumbs Up From EU Regulator
July 22, 2022
Via
Benzinga
EU, Bavarian Nordic Ink Supply Pact For 110,000 Monkeypox Vaccines
June 14, 2022
Via
Benzinga
Bavarian Nordic's Monkeypox Vaccine Scores EU Approval As WHO Declares Global Health Emergency
July 25, 2022
Via
Benzinga
Benzinga Before The Bell: Snap's Dismal Earnings, Amazon's Healthcare Foray, Robinhood Moves 41B Dogecoin Into Single Wallet And Other Top Financial Stories Friday, July 22
July 22, 2022
Reuters
Via
Benzinga
The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings
July 19, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
The Daily Biotech Pulse: Sesen Bio Stops Lead Assest Development In US, FDA Approves Eton Pharma's Partial Seizures Drug, Bavarian Nordic Inks Multiple Supply Pact For Monkeypox Vaccine
July 18, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Bavarian Nordic Inks Multiple Supply Pact For Its Monkey pox Vaccine, Updates FY22 Guidance
July 18, 2022
Via
Benzinga
Lawmaker Warns San Francisco Faces 'Public Health Mess' Over Monkeypox Vaccine Shortage
July 14, 2022
A California state legislator representing the Bay Area declared San Francisco is "veering toward a public health mess" after the city’s Department of Public Health acknowledged it is running out of...
Via
Benzinga
Quest Diagnostics Unveils Monkeypox Test: What You Need To Know
July 13, 2022
Quest Diagnostics (NYSE: DGX) has announced the nationwide availability of a lab-developed, automated molecular diagnostic test to identify if a person is infected with monkeypox.
Via
Benzinga
20% Of US Monkeypox Cases Are In This City
July 08, 2022
New York City has become the monkeypox capital of the U.S., with nearly 20% of the nation’s reported cases. What Happened: According to the New York Post, the city recorded 119 cases as of Wednesday....
Via
Benzinga
Monkeypox Stocks BVNRY, EBS, CMRX, SIGA Heat Up on U.S. Vaccine Stockpile
June 29, 2022
Pharmaceutical companies that make vaccines against monkeypox are getting attention as demand for treatments against the virus grow.
Via
InvestorPlace
White House Outlines New Monkeypox Vaccine Strategy: What You Need To Know
June 29, 2022
Via
Benzinga
Bavarian Nordic Launches COVID-19 Booster Study To Compare Against Pfizer/BioNTech Shot
June 16, 2022
Via
Benzinga
Morning Brief: Top Financial Stories Dominating on Tuesday, June 14
June 14, 2022
CNBC
Via
Benzinga
7 Monkeypox Stocks That May Take Off in Q2
June 09, 2022
SIGA Technologies (SIGA) may lead on the list of Monkeypox stocks that could soar, but Bavarian Nordic seems to be leading the sales race.
Via
InvestorPlace
Why Is AIkido Pharma (AIKI) Stock Up 1,400%?
June 07, 2022
AIkido Pharma (AIKI) stock is skyrocketing on Tuesday but it's not due to any positive news from the biotechnology company.
Via
InvestorPlace
Bavarian Nordic (BVNRY) Stock Gets a Boost From New Canadian Contract
June 07, 2022
Bavarian Nordic (BVNRY) stock is rising higher on Tuesday after announcing a new deal with Canada to purchase one of its vaccines.
Via
InvestorPlace
Monkeypox Outbreak Puts Focus On These Two Biotechs
May 27, 2022
Just when you thought it was safe to go outside, monkeypox pops up. Still, this might not be bad news for the market, as the world will turn once again to vaccine makers to find a solution.
Via
Talk Markets
This Famed Company Is Working On A Potential Monkeypox Vaccine
May 24, 2022
As cases of monkeypox continue to rise, Moderna Inc (NASDAQ: MRNA) is probably working on its platform towards finding a vaccine shot against the disease.
Via
Benzinga
7 Monkeypox Stocks to Watch Right Now
May 24, 2022
Wondering what are the best monkeypox stocks to watch? Here are the companies producing vaccines to help fight the spread of the virus.
Via
InvestorPlace
Analysis: Should You Be Afraid Of A Monkeypox Pandemic?
May 20, 2022
The coronavirus pandemic has yet to be firmly tucked into the history books even as a new health threat emerges: monkeypox, a rare infectious virus that has suddenly become more prevalent in Europe and...
Via
Benzinga
Bavarian Nordic (BVNRY) Stock Jumps 70% on Monkeypox Vaccine Order
May 19, 2022
Bavarian Nordic is soaring today as monkeypox cases shine a light on its vaccine. Here's what investors need to know about BVNRY stock.
Via
InvestorPlace
Week In Review: Nuance In-Licenses RSV Vaccine In $225 Million Deal
March 26, 2022
Shanghai Nuance Pharma in-licensed China and Southeast Asia rights to a respiratory syncytial virus (RSV) vaccine from Copenhagen’s Bavarian Nordic in a $225 million deal. The vaccine is aimed at older...
Via
Talk Markets
The Old Lady Of Threadneedle Street
November 05, 2021
US markets are up on better jobs growth reported for October today.
Via
Talk Markets
Global Stocks & Commodities Update
August 23, 2021
A quick look at oil, cobalt, and some of the stocks in my portfolio.
Via
Talk Markets
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.